Brought to you by 
Kyowa gets Japanese rights to ER quetiapine fumarate from Astellas
10 Mar 2017
Executive Summary
Astellas Pharma Inc. licensed Kyowa Pharmaceutical Industry Co. Ltd. exclusive rights to distribute and promote extended-release quetiapine fumarate tablets in Japan.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Kyowa gets Japanese rights to ER quetiapine fumarate from Astellas
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice